{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:35:32Z","timestamp":1774697732538,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,12]]},"DOI":"10.7759\/cureus.78913","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:11:06Z","timestamp":1739409066000},"source":"Crossref","is-referenced-by-count":2,"title":["Use of Anticoagulation for Secondary Stroke Prevention in Cerebral Cavernous Malformations: A Case Report"],"prefix":"10.7759","author":[{"given":"Lisle W","family":"Blackbourn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J","family":"Comardelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3171\/2023.7.FOCUS23355","article-title":"Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study","volume":"55","author":"Scerrati A","year":"2023","unstructured":"Scerrati A, Mantovani G, Travaglini F, et al.. Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study. Neurosurg Focus. 2023, 55:E15. 10.3171\/2023.7.FOCUS23355","journal-title":"Neurosurg Focus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00303-8","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne MA","year":"2016","unstructured":"Horne MA, Flemming KD, Su IC, et al.. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016, 15:166-73. 10.1016\/S1474-4422(15)00303-8","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032910","article-title":"Antithrombotic therapy in cerebral cavernous malformations: a systematic review, meta-analysis, and network meta-analysis","volume":"13","author":"Musmar B","year":"2024","unstructured":"Musmar B, Salim H, Abdelgadir J, et al.. Antithrombotic therapy in cerebral cavernous malformations: a systematic review, meta-analysis, and network meta-analysis. J Am Heart Assoc. 2024, 13:e032910. 10.1161\/JAHA.123.032910","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and thromboembolism prevention in atrial fibrillation","volume":"106","author":"Jame S","year":"2020","unstructured":"Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020, 106:10-7. 10.1136\/heartjnl-2019-314898","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.07.014","article-title":"Minimum national prevalence of diagnosed atrial fibrillation inferred from California acute care facilities","volume":"84","author":"Noubiap JJ","year":"2024","unstructured":"Noubiap JJ, Tang JJ, Teraoka JT, Dewland TA, Marcus GM. Minimum national prevalence of diagnosed atrial fibrillation inferred from California acute care facilities. J Am Coll Cardiol. 2024, 84:1501-8. 10.1016\/j.jacc.2024.07.014","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris PE","year":"2017","unstructured":"Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017, 40:413-8. 10.1002\/clc.22667","journal-title":"Clin Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000529511","article-title":"Impact of long-term antithrombotic and statin therapy on the clinical outcome in patients with cavernous malformations of the central nervous system: a single-center case series of 428 patients","volume":"52","author":"Wildi S","year":"2023","unstructured":"Wildi S, Nager S, Akeret K, et al.. Impact of long-term antithrombotic and statin therapy on the clinical outcome in patients with cavernous malformations of the central nervous system: a single-center case series of 428 patients. Cerebrovasc Dis. 2023, 52:634-42. 10.1159\/000529511","journal-title":"Cerebrovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2015.11.003","article-title":"Propranolol treatment of cavernous malformations with symptomatic hemorrhage","volume":"88","author":"Zabramski JM","year":"2016","unstructured":"Zabramski JM, Kalani MY, Filippidis AS, Spetzler RF. Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg. 2016, 88:631-9. 10.1016\/j.wneu.2015.11.003","journal-title":"World Neurosurg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002701","article-title":"Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies","volume":"86","author":"Taslimi S","year":"2016","unstructured":"Taslimi S, Modabbernia A, Amin-Hanjani S, Barker FG 2nd, Macdonald RL. Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology. 2016, 86:1984-91. 10.1212\/WNL.0000000000002701","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae398","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives","volume":"45","author":"Landmesser U","year":"2024","unstructured":"Landmesser U, Skurk C, Tzikas A, Falk V, Reddy VY, Windecker S. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives. Eur Heart J. 2024, 45:2914-32. 10.1093\/eurheartj\/ehae398","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/333755-use-of-anticoagulation-for-secondary-stroke-prevention-in-cerebral-cavernous-malformations-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:11:07Z","timestamp":1739409067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/333755-use-of-anticoagulation-for-secondary-stroke-prevention-in-cerebral-cavernous-malformations-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.78913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}